Alan Baratz

Alan Baratz, CEO of D-Wave, shares insights on the deployment of the Advantage2 quantum computer in Europe, emphasizing its impressive qubit count and potential applications. He discusses how D-Wave's technology is paving the way for advances in commercial and research sectors. Additionally, the podcast highlights ASML’s robust earnings amid the AI boom, the strategic shift of Apple’s in-house chips, and booming AI data center deals shaping the tech landscape.

Bob Bradway, Chairman and CEO of Amgen, shares groundbreaking phase three results for Repatha, showing promise in heart-attack prevention, and introduces Meritide, a potential game-changer for obesity and diabetes. Meanwhile, Dr. Alan Baratz, CEO of D-Wave Quantum, discusses the rapid commercial adoption of their quantum systems, highlighting major clients like Japan Tobacco. Baratz also delves into the technical innovations behind D-Wave's offerings and the competitive landscape in quantum computing.

Alan Baratz, CEO of D-Wave Quantum, discusses the transformative potential of quantum computing and its real-world applications. The conversation delves into how advancements in this field could redefine industries. They also explore the implications of Biden's restrictions on tech trade with China, particularly NVIDIA's strategy. Interesting connections are made between quantum computing and the evolving tech landscape, emphasizing the innovative paths ahead for both startups and established companies.